Selecta Biosciences

edit

Selecta Biosciences is a biopharmaceutical company developing the first generation of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. Our proprietary product platform technology combines recent advances in immunobiology with cutting-edge nanotechnology to develop targeted immunomodulatory nanoparticles.

Milestones

edit

• Received $15.1M in Series B funding. (2/25/09)
  Posted 4/14/09 at 10:01am

Videos

Screenshots

edit

Sources

1. Selecta Biosciences, Inc. Closes $15.1M Series B Financing (selectabio.com) [edit]